<DOC>
	<DOC>NCT00000244</DOC>
	<brief_summary>The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.</brief_summary>
	<brief_title>Effects of Dynorphin 1-13 on Heroin Addiction - 1</brief_title>
	<detailed_description>Randomized double blinded study of the effects of a single IV dose of dynorphin A 1-13 on heroin withdrawal in human opiate addicts</detailed_description>
	<mesh_term>Behavior, Addictive</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Substance Withdrawal Syndrome</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Dynorphins</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>opiate addict between the ages of 1855 Regular abuse of other drugs, unstable medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>addiction</keyword>
	<keyword>opiate</keyword>
	<keyword>heroin</keyword>
	<keyword>dynorphin</keyword>
</DOC>